Consolidated Statement of Changes in Net Equity

Balance as of January 1, 2012¹

397.2

168.0

3,813.7

5,237.1

-378.2

0.8

-94.6

1,304.0

10,448.0

46.3

10,494.3

Profit after tax¹

–

–

–

172.7

–

–

–

–

172.7

2.4

175.1

Other comprehensive income¹

–

–

–

–

–

–

57.5

–19.2

38.3

–0.2

38.1

Comprehensive income¹

–

–

–

172.7

–

–

57.5

–19.2

210.9

2.3

213.2

Dividend payments

–

–

–

–

–

–

–

–

–

–0.7

–0.7

Profit transfers to/from E. Merck KG including changes in reserves

–

–

–

–69.0

–

–

–

–

–69.0

–

–69.0

Changes in scope of consolidation/Other

–

–

–

0.6

–

–

–

–

0.6

–0.2

0.4

Balance as of March 31, 2012¹

397.2

168.0

3,813.7

5,341.4

–378.2

0.8

–37.1

1,284.8

10,590.6

47.6

10,638.2

Balance as of January 1, 2013

397.2

168.0

3,813.7

5,383.9

–645.3

1.2

–29.5

1,272.2

10,361.4

53.4

10,414.8

Profit after tax

–

–

–

266.0

–

–

–

–

266.0

3.0

269.0

Other comprehensive income

–

–

–

–

–73.1

0.3

–17.0

19.2

–70.6

1.8

–68.8

Comprehensive income

–

–

–

266.0

–73.1

0.3

–17.0

19.2

195.4

4.8

200.2

Dividend payments

–

–

–

–

–

–

–

–

–

–1.9

–1.9

Profit transfers to/from E. Merck KG including changes in reserves

–

–

–

–98.7

–

–

–

–

–98.7

–

–98.7

Transactions with no change of control

–

–

–

2.1

–

–

–

–

2.1

–2.1

–

Changes in scope of consolidation/Other

–

–

–

0.2

–

–

–

–

0.2

–0.2

–

Balance as of March 31, 2013

397.2

168.0

3,813.7

5,553.4

–718.4

1.5

–46.5

1,291.4

10,460.3

54.0

10,514.3